Number of the records: 1
Chemosensitization of tumors via simultaneous delivery of STAT3 inhibitor and doxorubicin through HPMA copolymer-based nanotherapeutics with pH-sensitive activation.
- 1.
SYSNO 0580702 Title Chemosensitization of tumors via simultaneous delivery of STAT3 inhibitor and doxorubicin through HPMA copolymer-based nanotherapeutics with pH-sensitive activation. Author(s) Kovář, Marek (MBU-M) RID, ORCID
Šubr, Vladimír (UMCH-V) [BIOMOL] RID, ORCID
Běhalová, Kateřina (MBU-M) ORCID
Studenovský, Martin (UMCH-V) [BIOMOL] RID, ORCID
Starenko, Daniil (MBU-M)
Kovářová, Jiřina (MBU-M)
Procházková, Petra (MBU-M) RID, ORCID
Etrych, Tomáš (UMCH-V) [BIOMOL] RID, ORCID
Kostka, Libor (UMCH-V) [BIOMOL] RID, ORCIDCorespondence/senior Kostka, Libor - Korespondující autor Source Title Nanomedicine: Nanotechnology, Biology and Medicine. Roč. 56, February 2024 (2024), s. 102730. - : Elsevier Document Type Článek v odborném periodiku Grant NU21-03-00273 GA MZd - Ministry of Health (MZ), CZ - Czech Republic LX22NPO5102 GA MŠMT - Ministry of Education, Youth and Sports (MEYS) Institutional support MBU-M - RVO:61388971 ; UMCH-V - RVO:61389013 Language eng Country NL Keywords STAT3 inhibitor * Doxorubicin * HPMA copolymer carrier * pH-sensitive drug * release URL https://www.sciencedirect.com/science/article/pii/S1549963423000813 Permanent Link https://hdl.handle.net/11104/0349459 File Download Size Commentary Version Access 0580702.pdf 10 5 MB CC BY license Publisher’s postprint open-access Kovar et al_Nanomedicine.pdf 0 5 MB Publisher’s postprint open-access
Number of the records: 1